US Stock MarketDetailed Quotes
ACET Adicet Bio
- 1.280
- -0.080-5.88%
Close Oct 31 16:00 ET
- 1.319
- +0.039+3.07%
Post 16:15 ET
105.47MMarket Cap-507P/E (TTM)
1.420High1.260Low287.77KVolume1.380Open1.360Pre Close378.44KTurnover0.46%Turnover RatioLossP/E (Static)82.40MShares3.77052wk High0.45P/B79.49MFloat Cap1.05052wk Low--Dividend TTM62.10MShs Float214.348Historical High--Div YieldTTM11.77%Amplitude0.931Historical Low1.315Avg Price1Lot Size
About Adicet Bio Company
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Company Profile
SymbolACET
Company NameAdicet Bio
Listing DateJan 26, 2018
Issue Price15.00
Founded2014
CEOMr. Chen Schor, M.B.A.
MarketNASDAQ
Employees143
Fiscal Year Ends12-31
Address131 Dartmouth Street,3rd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02116
Phone1-650-503-9095
Websitehttp://www.adicetbio.com
Company Executives
- Name
- Position
- Salary
- Chen Schor, M.B.A.
- Chief Executive Officer, President and Director
- 3.99M
- Nick Harvey
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Blake Aftab, PhD
- Chief Scientific Officer
- 2.48M
- Dr. Francesco Galimi, M.D.,PhD
- Chief Medical Officer
- 1.99M
- Dr. Donald Healey, PhD
- Chief Technology Officer
- --
- Dr. Aya Jakobovits, PhD
- Independent Director
- 183.87K
- Katie Peng
- Independent Director
- --
- Dr. Jeffrey A. Chodakewitz, M.D.
- Independent Director
- 183.87K
- Steve Dubin, J.D.
- Independent Director
- 197.87K
- Dr. Andrew Sinclair, PhD
- Independent Director
- 194.37K
- Dr. Lloyd Klickstein, M.D.,PhD
- Independent Director
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- 218.87K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data